Internal Medicine · Santa Rosa, CA
NPI
1134349673
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3975 Old Redwood Hwy Ste 152
Santa Rosa, CA, 95403
Phone (075) 665-8757
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$202K
846 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Madhavi Vetsa prescribed most often to Medicare patients was Omeprazole, with 136 prescriptions and refills. In total Madhavi Vetsa wrote 846 Medicare prescriptions that cost $202K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Omeprazole Generic | 136 | 244 | 63 | $1,476 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 111 | 111 | 111 | $2,483 |
| Pantoprazole Sodium Generic | 93 | 216 | 34 | $1,407 |
| Mesalamine Generic | 75 | 184 | 24 | $30K |
| Dicyclomine Hcl Generic | 37 | 44 | 16 | $1,249 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 32 | 33 | Under 11 | $555 |
| Esomeprazole Magnesium Generic | 30 | 53 | 12 | $753 |
| Creon Lipase/Protease/Amylase | 26 | 46 | Under 11 | $64K |
| Ondansetron Hcl Generic | 23 | 23 | Under 11 | $166 |
| Neomycin Sulfate Generic | 22 | 27 | 16 | $2,260 |
| Tramadol Hcl Generic | 18 | 18 | Under 11 | $121 |
| Cholestyramine Cholestyramine (With Sugar) | 17 | 23 | Under 11 | $1,151 |
| Budesonide Dr Budesonide | 17 | 28 | Under 11 | $1,496 |
| Ursodiol Generic | 13 | 38 | Under 11 | $3,444 |
| Xifaxan Rifaximin | 12 | 12 | Under 11 | $34K |
Brand drugs: 86 claims; generic drugs: 760 claims; opioid claims: 23.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Madhavi Vetsa were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.